Skip to main content
. 2022 Apr 14;2022(4):CD013696. doi: 10.1002/14651858.CD013696.pub2

Singh 2014.

Study characteristics
Methods Study design: RCT
Location: not reported
Setting: community
Recruitment: by referrals from families, supported living and group home supervisors, and primary care physicians
Study dates: not reported
Participants N = 51
Specialist population?: adults with mild intellectual disability
Definition of smoker used: unclear
Participant characteristics: 18% female; average age: 34 years; average cpd: 12; average years smoking: 16
Interventions Comparator: treatment as usual, including motivational therapies, behaviour therapies, NRTs, non‐nicotine medicines, or a combination of the above
Mode of delivery: not reported
Intensity: unclear, varied across participants
Pharmacotherapy: none specifically provided, although for some usual care included NRT
Type of therapist/provider: community therapists
BCTs: 2.3 Self‐monitoring (behaviour), 11.1 Pharmacological support
Intervention: training in the use of mindfulness and meditation techniques
Mode of delivery: face‐to‐face (individual or small groups) or via Skype
Intensity: 2 training sessions (1 x 1 h, 1 x 45 min), 10 supervised practice sessions (x 30 min over 5 days), weekly contact with trainer
Pharmacotherapy: none
Type of therapist/provider: trainer with a 35‐year history of service provision to people with intellectual and developmental disabilities and long‐standing personal meditation practice, clinical expertise, and experience in mindful service delivery to individuals at all levels of intellectual functioning 
BCTs: 1.9 Commitment, 2.3 Self‐monitoring of behaviour, 12.4 Distraction, 12.6 Body changes
Outcomes Definition of abstinence: 7‐day point prevalence
Longest follow‐up: 12 months
Biochemical verification: none
Other relevant outcomes reported: none
Notes Relevant comparisons: mindfulness and meditation training vs treatment as usual
Funding source: not reported
Author conflicts of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) High risk Randomisation was via alternate placement in the experimental and control groups
Allocation concealment (selection bias) Unclear risk Concealment not reported
Blinding of outcome assessment (detection bias)
All outcomes High risk Abstinence self‐reported, differing levels of face‐to‐face contact between arms
Incomplete outcome data (attrition bias)
All outcomes Unclear risk Only reported attrition during treatment
Selective reporting (reporting bias) Unclear risk No protocol available